{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:31:30Z","timestamp":1791502290961,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jmii.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T03:39:08Z","timestamp":1709696348000},"page":"365-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan"],"prefix":"10.1016","volume":"57","author":[{"given":"Yi-Che","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ting","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Liang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran-Der","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-6265","authenticated-orcid":false,"given":"Yi-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Wei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-9194","authenticated-orcid":false,"given":"Yi-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-4281","authenticated-orcid":false,"given":"Yao-Yu","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-5508","authenticated-orcid":false,"given":"Ming-Yang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hau","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-0850","authenticated-orcid":false,"given":"Shu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Sheng","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2024.02.005_bib1","series-title":"Hematopoietic stem cell transplantation","author":"Khaddour","year":"2022"},{"issue":"8","key":"10.1016\/j.jmii.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","article-title":"An overview of infectious complications after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Sahin","year":"2016","journal-title":"J Infect Chemother"},{"issue":"5","key":"10.1016\/j.jmii.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/microorganisms8050685","article-title":"Where do we stand after decades of studying human cytomegalovirus?","volume":"8","author":"Gugliesi","year":"2020","journal-title":"Microorganisms"},{"issue":"3\u20134","key":"10.1016\/j.jmii.2024.02.005_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-3062.2005.000111.x","article-title":"Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program","volume":"7","author":"Rossini","year":"2005","journal-title":"Transplant Infect Dis"},{"issue":"8","key":"10.1016\/j.jmii.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00277-016-2700-4","article-title":"Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab","volume":"95","author":"Jain","year":"2016","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.jmii.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2141.2001.02487.x","article-title":"Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma","volume":"112","author":"Fassas","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jmii.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","article-title":"Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation","volume":"7","author":"Styczynski","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"1","key":"10.1016\/j.jmii.2024.02.005_bib8","doi-asserted-by":"crossref","first-page":"82.e1","DOI":"10.1016\/j.bbmt.2020.10.001","volume":"27","author":"Takenaka","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jmii.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","article-title":"Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: the Japan society for hematopoietic C.","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jmii.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1182\/bloodadvances.2019000814","article-title":"Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation","volume":"4","author":"Kaito","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jmii.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/jof8040408","article-title":"Revisit of the association between cytomegalovirus infection and invasive fungal infection after allogeneic hematopoietic stem cell transplantation: a real-world analysis from a high CMV seroprevalence area","volume":"8","author":"Yeh","year":"2022","journal-title":"J Fungi"},{"issue":"4","key":"10.1016\/j.jmii.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00277-011-1351-8","article-title":"Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus","volume":"91","author":"Liu","year":"2012","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.jmii.2024.02.005_bib13","first-page":"6551","article-title":"Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: proposal for classification","volume":"37","author":"Dziedzic","year":"2017","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.jmii.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bmt.1704232","article-title":"Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Yanada","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"20","key":"10.1016\/j.jmii.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jmii.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jmii.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"446","key":"10.1016\/j.jmii.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"10.1016\/j.jmii.2024.02.005_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1702805","article-title":"Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan","volume":"27","author":"Kanda","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jmii.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1532\/IJH97.A30402","article-title":"Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea","volume":"81","author":"Choi","year":"2005","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.jmii.2024.02.005_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx050","article-title":"Infections in hematopoietic cell transplant recipients: results from the organ transplant infection project, a multicenter, prospective, cohort study","volume":"4","author":"Schuster","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.jmii.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/JCM.01670-06","article-title":"Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer","volume":"45","author":"Han","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.jmii.2024.02.005_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jinf.2015.11.005","article-title":"Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant","volume":"72","author":"Mengarelli","year":"2016","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jmii.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.htct.2018.10.004","article-title":"Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years","volume":"42","author":"Diaz","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"10.1016\/j.jmii.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.02.005_bib26","author":"Auletta"},{"issue":"13","key":"10.1016\/j.jmii.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/CM9.0000000000001575","article-title":"A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China","volume":"134","author":"Gu","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.jmii.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"JClin Oncol"},{"issue":"4","key":"10.1016\/j.jmii.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bmt.2015.330","article-title":"Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Tanaka","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jmii.2024.02.005_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy","volume":"12","author":"George","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.jmii.2024.02.005_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00277-003-0706-1","article-title":"Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation","volume":"82","author":"Nachbaur","year":"2003","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.jmii.2024.02.005_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbmt.2009.02.009","article-title":"Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation","volume":"15","author":"Nakamae","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jmii.2024.02.005_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4274\/tjh.2016.0225","article-title":"Cytomegalovirus infection and treatment in allogeneic hematopoietic stem cell transplantation: a retrospective study from a single institution in an endemic area","volume":"34","author":"Lin","year":"2017","journal-title":"Turk J Haematol"},{"issue":"12","key":"10.1016\/j.jmii.2024.02.005_bib34","article-title":"Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: proposal for classification","volume":"37","author":"Dziedzic","year":"2017","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.jmii.2024.02.005_bib35","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3390\/ijms20112666","article-title":"Cytomegalovirus Infections after Hematopoietic stem cell transplantation: current status and future immunotherapy","volume":"20","author":"Cho","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jmii.2024.02.005_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.htct.2018.10.004","article-title":"Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years","volume":"42","author":"Diaz","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"10.1016\/j.jmii.2024.02.005_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.bmt.1705699","article-title":"Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies","volume":"40","author":"\u00d6zdemir","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jmii.2024.02.005_bib38","doi-asserted-by":"crossref","first-page":"e13096","DOI":"10.1111\/tid.13096","article-title":"Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia","volume":"21","author":"Lin","year":"2019","journal-title":"Transpl Infect Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:48:56Z","timestamp":1717501736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118224000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1684118224000434"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2024.02.005","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}